IPR scenario and factors for promoting IPR culture: a post-TRIPS period analysis of selected pharmaceutical firms in North India

Ravi Kiran

Economic Research-Ekonomska Istraživanja, 2017, vol. 30, issue 1, 873-891

Abstract: Different shades of World Trade Organization (WTO) agreement on trade-related intellectual property rights (TRIPS) are reflected in the Indian pharmaceutical industry, but small and medium-scale pharmaceutical firms are slowly increasing their product innovation, process innovation and research and development (R&D) intensity. Analysis of variance results highlight a significant difference in performance of sole proprietorship/partnership, private limited and public limited firms vis-à-vis product innovation, process innovation, increased range of goods and services, R&D intensity, new technology adoption and adaptation. Factor analysis results indicated that developing intellectual property rights (IPR), technological measures and marketing practices explained 80.256% of variation. Policy initiative factor is dominating and SMEs are still relying heavily on support from government.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/1331677X.2017.1311223 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:reroxx:v:30:y:2017:i:1:p:873-891

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/rero20

DOI: 10.1080/1331677X.2017.1311223

Access Statistics for this article

Economic Research-Ekonomska Istraživanja is currently edited by Marinko Skare

More articles in Economic Research-Ekonomska Istraživanja from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().